| ED North Database | | Lindane (gamma-Hexachlorocyclohexane) |
| Study details | | Group | mammalian | | Organism | Long Evans rat, female | | Tissue | | | Age | 21 days | | InVivo | In vivo | | Lab | Laboratory | | Flow | | | Duration | 5 days | | Route | Oral | | Temperature | | | Concentration | 10-40 mg/kg | | Notes | Ovariectomized and 17-beta-estradiol-3-benzoate (EB)-primed |
|
|
| Described effects | | suspected no endocrine effect No effects on serum estradiol and uterine progesterone concentrations | | suspected no endocrine effect No effects on ER binding | | suspected no endocrine effect No effects on pituitary and uterus weight |
|
| Literature references | | Laws, S.C., Carey, S.A., Hart, D.W., Cooper, R.L.(1994). Lindane does not alter the estrogen receptor or the estrogen-dependent induction of progesterone receptors in sexually immature or ovariectomized adult rats.Toxicology 92:127-142 |
|
|